Innovation | Published:

Healing sound: the use of ultrasound in drug delivery and other therapeutic applications

Nature Reviews Drug Discovery 4, 255–260 (2005) | Download Citation

Subjects

Abstract

Ultrasound, which is routinely used for diagnostic imaging applications, is now being adopted in various drug delivery and other therapeutic applications. Ultrasound has been shown to facilitate the delivery of drugs across the skin, promote gene therapy to targeted tissues, deliver chemotherapeutic drugs into tumours and deliver thrombolytic drugs into blood clots. In addition, ultrasound has also been shown to facilitate the healing of wounds and bone fractures. This article reviews the principles and current status of ultrasound-based treatments.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

Rent or Buy

All prices are NET prices.

References

  1. 1.

    & Ultrasound in pregnancy. Emerg. Med. Clin. North Am. 22, 697–722 (2004).

  2. 2.

    Microbubbles in medical imaging: current applications and future directions. Nature Rev. Drug Discov. 3, 527–532 (2004).

  3. 3.

    Ultrasound: Its Chemical, Physical and Biological Effects (VCH, New York, 1988).

  4. 4.

    & Microimplosions: cavitation collapse and shock wave emission on a nanosecond time scale. Phys. Rev. Lett. 84, 1328–1330 (2000).

  5. 5.

    & Sonochemical free radical formation in aqueous solutions. Fed. Proc. 45, 2485–2492 (1986).

  6. 6.

    & Klinik and therapies des chromischen gelenkreumatismus. Maudrich Vienna, Austria 549–552 (1954).

  7. 7.

    , , & Frequency dependence of sonophoresis. Pharm. Res. 18, 1694–1700 (2001).

  8. 8.

    , & Ultrasound-mediated transdermal protein delivery. Science 269, 850–853 (1995).

  9. 9.

    , , , & Effect of sonication parameters on transdemral delivery of insulin to hairless rats. J. Pharm. Sci. 91, 113–119 (2002).

  10. 10.

    & Low-frequency sonophoresis: a review. Adv. Drug Deliv. Rev. 56, 589–601 (2004).

  11. 11.

    , , & A mechanistic study of ultrasonically-enhanced transdermal drug delivery. J. Pharm. Sci. 84, 697–706 (1995).

  12. 12.

    & Interactions of inertial cavitation bubbles with stratum corneum lipid bilayers during low-frequency sonophoresis. Biophys. J. 85, 3502–3512 (2003).

  13. 13.

    , , , & Transdermal monitoring of glucose and other analytes using ultrasound. Nature Med. 6, 347–350 (2000).

  14. 14.

    , , , & Radionuclide tumour therapy with ultrasound contrast microbubbles. Ultrasonics 42, 903–906 (2004).

  15. 15.

    et al. Enhanced cytotoxic effect of Ara-C by low intensity ultrasound to HL-60 cells. Cancer Lett. 149, 189–194 (2000).

  16. 16.

    et al. Ultrasonic-enhanced gentamicin transport through colony biofilms of Pseudomonas aeruginosa and Escherichia coli. J. Infect. Chemother. 10, 193–199 (2004).

  17. 17.

    & Low-intensity phonophoresis of cortisol in swine. Phys. Ther. 48, 1336–1344 (1968).

  18. 18.

    , , , & Treatment of transplanted adriamycin-resistant ovarian cancers in mice by combination of adriamycin and ultrasound exposure. Ultrason. Sonochem. 11, 287–291 (2004).

  19. 19.

    et al. High-intensity focused ultrasound selectively disrupts the blood–brain barrier in vivo. Ultrasound Med. Biol. 28, 389–400 (2002).

  20. 20.

    , , & Non-invasive opening of BBB by focused ultrasound. Acta Neurochir. Suppl. 86, 555–558 (2003).

  21. 21.

    , & Drug delivery into the eye with the use of ultrasound. J. Ultrasound Med. 23, 1349–1359 (2004).

  22. 22.

    , , & Ocular drug delivery using 20-kHz ultrasound. Ultrasound Med. Biol. 28, 823–829 (2002).

  23. 23.

    , , , & Ultrasound-triggered drug targeting of tumors in vitro and in vivo. Ultrasonics 42, 943–950 (2004).

  24. 24.

    , , , & Ultrasonically activated chemotherapeutic drug delivery in a rat model. Cancer Res. 62, 7280–7283 (2002).

  25. 25.

    & Acoustically active liposomes for drug encapsulation and ultrasound-triggered release. Biochim. Biophys. Acta 1665, 134–141 (2004).

  26. 26.

    , , & Self-assembled molecular structures as ultrasonically-responsive barrier membranes for pulsatile drug delivery. J. Biomed. Mater. Res. 57, 151–164 (2001).

  27. 27.

    , & Ultrasound-enhanced polymer degradation and release of incorporated substances. Proc. Natl Acad. Sci. USA 86, 7663–7666 (1989).

  28. 28.

    , , & Equilibrium loading of cells with macromolecules by ultrasound: effects of molecular size and acoustic energy. J. Pharm. Sci. 91, 1693–1701 (2002).

  29. 29.

    , , , & Intracellular drug delivery using low-frequency ultrasound: quantification of molecular uptake and cell viability. Pharm. Res. 18, 1514–1520 (2001).

  30. 30.

    , & An experimental and theoretical analysis of ultrasound-induced permeabilization of cell membranes. Biophys. J. 84, 3087–3101 (2003).

  31. 31.

    et al. Transfection of NFκB-decoy oligodeoxynucleotides using efficient ultrasound-mediated gene transfer into donor kidneys prolonged survival of rat renal allografts. Gene Ther. 10, 415–425 (2003).

  32. 32.

    et al. Focused ultrasound (HIFU) induces localized enhancement of reporter gene expression in rabbit carotid artery. Gene Ther. 10, 1600–1607 (2003).

  33. 33.

    et al. Ultrasound enhancement of cationic lipid-mediated gene transfer to primary tumors following systemic administration. Gene Ther. 7, 1833–1839 (2000).

  34. 34.

    et al. Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation 105, 1233–1239 (2002).

  35. 35.

    & Physical parameters influencing optimization of ultrasound-mediated DNA transfection. Ultrasound Med. Biol. 30, 527–538 (2004).

  36. 36.

    , & A review of research into the uses of low level ultrasound in cancer therapy. Ultrason. Sonochem. 11, 95–103 (2004).

  37. 37.

    , , , & Induction of cell-membrane porosity by ultrasound. Lancet 353, 1409 (1999).

  38. 38.

    , , & Eliminating adult T-cell leukaemia cells with ultrasound. Lancet 349, 325 (1997).

  39. 39.

    et al. Targeted sonodynamic therapy of cancer using a photosensitizer conjugated with antibody against carcinoembryonic antigen. Anticancer Res. 22, 1575–1580 (2002).

  40. 40.

    , , & Sonodynamic therapy on chemically induced mammary tumor: pharmacokinetics, tissue distribution and sonodynamically induced antitumor effect of porfimer sodium. Cancer Sci. 95, 765–769 (2004).

  41. 41.

    et al. Ultrastructure of sarcoma 180 cells after ultrasound irradiation in the presence of sparfloxacin. Anticancer Res. 24, 1553–1559 (2004).

  42. 42.

    , & Induction of selective cytotoxicity in skin and prostate cancer cells using quercetin and ultrasound. Br. J. Cancer 01 Feb 2005 (10.1038/sj.bjc.6602364).

  43. 43.

    , & Sonodynamic therapy — a review of the synergistic effects of drugs and ultrasound. Ultrason. Sonochem. 11, 349–363 (2004).

  44. 44.

    et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N. Engl. J. Med. 351, 2170–2178 (2004).

  45. 45.

    & Ultrasound in the treatment of ischaemic stroke. Lancet Neurol. 2, 283–290 (2003).

  46. 46.

    & Therapeutic ultrasound in ischemic stroke treatment: experimental evidence. Eur. J. Ultrasound 16, 121–130 (2002).

  47. 47.

    & Cavitational mechanisms in ultrasound-accelerated thrombolysis at 1 MHz. Ultrasound Med. Biol. 26, 1153–1160 (2000).

  48. 48.

    Ultrasound enhancement of thrombolytic therapy: observations and mechanisms. Int. J. Cardiovasc. Intervent. 3, 81–89 (2000).

  49. 49.

    , , & Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots. Ultrasound Med. Biol. 21, 419–424 (1995).

  50. 50.

    The use of ultrasound therapy in wound healing. J. Wound Care 7, 25–28 (1998).

  51. 51.

    et al. Ultrasound accelerates functional recovery after peripheral nerve damage. Neurosurgery 48, 1136–1140 (2001).

  52. 52.

    , , & Enhancement of fracture healing by low intensity ultrasound. Clin. Orthop. 355, S216–229 (1998).

  53. 53.

    et al. Improved cartilage repair after treatment with low-intensity pulsed ultrasound. Clin. Orthop. 391, S231–243 (2001).

  54. 54.

    & The action of low-intensity pulsed ultrasound in bones of osteopenic rats. Artif. Organs 28, 114–118 (2004).

  55. 55.

    , , & In vitro effects of therapeutic ultrasound on cell proliferation, protein synthesis, and cytokine production by human fibroblasts, osteoblasts, and monocytes. J. Oral Maxillofac. Surg. 57, 409–419 (1999).

  56. 56.

    et al. Ultrasonic low-energy treatment: a novel approach to induce apoptosis in human leukemic cells. Exp. Hematol. 30, 1293–12301 (2002).

  57. 57.

    et al. Intravascular sonotherapy decreases neointimal hyperplasia after stent implantation in swine. Circulation 103, 1828–1831 (2001).

  58. 58.

    et al. Use of therapeutic ultrasound in percutaneous coronary angioplasty. Experimental in vitro studies and initial clinical experience. Circulation 89, 1587–1592 (1994).

  59. 59.

    & A review and examination of ultrasound for lipoplasty. Clin. Plast. Surg. 26, 409–422 (1999).

  60. 60.

    , , & High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience. Urology 63, 297–300 (2004).

  61. 61.

    , , , & High intensity focused ultrasound as noninvasive therapy for multilocal renal cell carcinoma: case study and review of the literature. J. Urol. 167, 2397–2403 (2002).

  62. 62.

    , & High intensity focused ultrasound: a method of hemostasis. Echocardiography 18, 309–315 (2001).

  63. 63.

    Biological effects of ultrasound: development of safety guidelines. Part II: general review. Ultrasound Med. Biol. 27, 301–333 (2001).

  64. 64.

    & Lung damage assessment from exposure to pulsed-wave ultrasound in the rabbit, mouse, and pig. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 44, 473–448 (1997).

Download references

Acknowledgements

S.M. acknowledges funding from Whitaker Foundation.

Author information

Affiliations

  1. Samir Mitragotri is Assistant Professor at the Department of Chemical Engineering, University of California, Santa Barbara, California 93106, USA  samir@engineering.ucsb.edu

    • Samir Mitragotri

Authors

  1. Search for Samir Mitragotri in:

Competing interests

S.M. is a stockholder in Sontra Medical Inc. and scientific advisor to CytoDome Inc.

FURTHER INFORMATION

To obtain permission to re-use content from this article visit RightsLink.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nrd1662

Further reading Further reading